NOTE TO THE FILE
SERIAL NUMBER: 88944197
DATE: 09/03/2020
NAME: wjun
NOTE:
Searched:
Lexis/Nexis
OneLook
Wikipedia
Acronym Finder Protest evidence reviewed
Other:Checked:
Geographic significance
Surname
Translation
ID with ID/CLASS mailboxChecked list of approved Canadian attorneys and agents
Discussed file with
Attorney/Applicant via:
phone Left message with
email Attorney/ApplicantRequested Law Library search Issued Examiner’s Amendment
for: and entered changes in TRADEUPSPRINT DO NOT PRINT Added design code in TRADEUPS
Description of the mark
Translation statement Re-imaged standard character
drawing
Negative translation statement
Consent of living individual Contacted TM MADRID ID/CLASS
about misclassified definite ID
Changed TRADEUPS to:From: Sean D. Detweiler <sdetweiler@morse.law>
Sent: Thursday, September 3, 2020 8:56 AM
To: Jun, Wendy <Wendy.Jun@USPTO.GOV>
Cc: Trademark <trademark@morse.law>
Subject: RE: SOLARA 88944197 (CYTLTM05)
Attorney Jun,
Thank you for your email. We approve the proposed examiner amendment.
Best,
Sean Detweiler
From: Trademark
Sent: Thursday, September 3, 2020 8:46 AM
To: Sean D. Detweiler <sdetweiler@morse.law>
Subject: FW: SOLARA 88944197
From: Jun, Wendy <Wendy.Jun@USPTO.GOV>
Sent: Wednesday, September 2, 2020 8:54 PM
To: Trademark <trademark@morse.law>
Subject: SOLARA 88944197
This email is intended for Sean Detweiler and/or any authorized party.
I am the trademark examining attorney handling the above case(s). I have reviewed your application/response and the identification(s) must be amended because the identification(s) of goods/services is/are indefinite. It feels like there is a word missing in the ID. Please see suggested insertion of the word “to”. The following is suggested:
Class 042 Platform as a service (PAAS) featuring computer software platforms for use by product development teams at pharmaceutical and biotech companies to design clinical trials and communicate study design recommendations to management and governance boards; Providing temporary use of non-downloadable cloud-based software for the creation and implementation of formulated decision guidelines for use in clinical development